Actively Recruiting

Age: 18Years +
All Genders
ID06218901

Association of Psychological Distress in Patients With Advanced Lung Cancer Treated With Immunotherapy or Targeted Therapy

Led by Shanghai Chest Hospital · Updated on 2025-05-22

500

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Psychological distress, involving emotional, social, spiritual, and physical challenges, can affect how well patients cope with lung cancer and its treatment. This research focuses on patients with advanced lung cancer receiving immunotherapy or targeted therapy, aiming to explore how psychological stress relates to treatment effectiveness and survival outcomes. Participants in this observational study are patients with advanced lung cancer undergoing immunotherapy or targeted molecular therapy. The study observes the association between their psychological distress and the results of these anti-tumor treatments, without introducing new treatments or interventions. During the study, researchers will track measures such as objective response rate, disease control rate, and progression-free survival over a 20-year period. Overall survival is also monitored as a secondary outcome. Participants will provide information through assessments related to psychological distress, which will help evaluate how stress impacts treatment outcomes and patient prognosis.

CONDITIONS

Brief Title

Association of Psychological Distress in Patients With Lung Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically proven diagnosis of lung cancer
  • 18 years of age or older
  • Ability to understand and the willingness to sign a written informed consent document
Not Eligible

You will not qualify if you...

  • Not willing to participate in this clinical trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 20 years

Participants are observed over time to assess psychological distress and disease outcomes while receiving immunotherapy or targeted therapy as part of their routine care.

Periodic visits depending on routine care schedules

Trial Site Locations

Total: 1 location

1

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China, 200030

Actively Recruiting

Loading map...

Research Team

X

Xiaomin Niu

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Preoperative 3-D Virtual Resection Predicts Lung Function Af...

Non-small Cell Lung Cancer

Actively Recruiting

1 location

A Pilot Study of 68Ga-FAPI-RGD PET/CT Imaging in Lung Cancer...

Lung Neoplasms

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here